Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
25,125
archived clinical trials in
Diabetes

Cinnamon Trial-lIfestyle iNtervention Plus Water-soluble Cinnamon Extract On loweriNg Blood Glucose in Pre-diabetics
Cinnamon Trial—Assessment of the effeCt of lIfestyle iNtervention Plus Water-soluble ciNnAMon Extract On loweriNg Blood Glucose in Pre-diabetics: A Randomized, Double-blind, Multicenter, Placebo Controlled TRIAL.
Status: Enrolling
Updated:  12/31/1969
Travis Air Force Base
mi
from
Travis Air Force Base, CA
Cinnamon Trial-lIfestyle iNtervention Plus Water-soluble Cinnamon Extract On loweriNg Blood Glucose in Pre-diabetics
Cinnamon Trial—Assessment of the effeCt of lIfestyle iNtervention Plus Water-soluble ciNnAMon Extract On loweriNg Blood Glucose in Pre-diabetics: A Randomized, Double-blind, Multicenter, Placebo Controlled TRIAL.
Status: Enrolling
Updated: 12/31/1969
Travis Air Force Base
mi
from
Travis Air Force Base, CA
Click here to add this to my saved trials
Cinnamon Trial-lIfestyle iNtervention Plus Water-soluble Cinnamon Extract On loweriNg Blood Glucose in Pre-diabetics
Cinnamon Trial—Assessment of the effeCt of lIfestyle iNtervention Plus Water-soluble ciNnAMon Extract On loweriNg Blood Glucose in Pre-diabetics: A Randomized, Double-blind, Multicenter, Placebo Controlled TRIAL.
Status: Enrolling
Updated:  12/31/1969
Eglin Air Foce Base
mi
from
Eglin Air Force Base, FL
Cinnamon Trial-lIfestyle iNtervention Plus Water-soluble Cinnamon Extract On loweriNg Blood Glucose in Pre-diabetics
Cinnamon Trial—Assessment of the effeCt of lIfestyle iNtervention Plus Water-soluble ciNnAMon Extract On loweriNg Blood Glucose in Pre-diabetics: A Randomized, Double-blind, Multicenter, Placebo Controlled TRIAL.
Status: Enrolling
Updated: 12/31/1969
Eglin Air Foce Base
mi
from
Eglin Air Force Base, FL
Click here to add this to my saved trials
Cinnamon Trial-lIfestyle iNtervention Plus Water-soluble Cinnamon Extract On loweriNg Blood Glucose in Pre-diabetics
Cinnamon Trial—Assessment of the effeCt of lIfestyle iNtervention Plus Water-soluble ciNnAMon Extract On loweriNg Blood Glucose in Pre-diabetics: A Randomized, Double-blind, Multicenter, Placebo Controlled TRIAL.
Status: Enrolling
Updated:  12/31/1969
Offutt Air Force Base
mi
from
Offutt Air Force Base, NE
Cinnamon Trial-lIfestyle iNtervention Plus Water-soluble Cinnamon Extract On loweriNg Blood Glucose in Pre-diabetics
Cinnamon Trial—Assessment of the effeCt of lIfestyle iNtervention Plus Water-soluble ciNnAMon Extract On loweriNg Blood Glucose in Pre-diabetics: A Randomized, Double-blind, Multicenter, Placebo Controlled TRIAL.
Status: Enrolling
Updated: 12/31/1969
Offutt Air Force Base
mi
from
Offutt Air Force Base, NE
Click here to add this to my saved trials
Cinnamon Trial-lIfestyle iNtervention Plus Water-soluble Cinnamon Extract On loweriNg Blood Glucose in Pre-diabetics
Cinnamon Trial—Assessment of the effeCt of lIfestyle iNtervention Plus Water-soluble ciNnAMon Extract On loweriNg Blood Glucose in Pre-diabetics: A Randomized, Double-blind, Multicenter, Placebo Controlled TRIAL.
Status: Enrolling
Updated:  12/31/1969
Wilford Hall Ambulatory Surgical Center
mi
from
Lackland Air Force Base, TX
Cinnamon Trial-lIfestyle iNtervention Plus Water-soluble Cinnamon Extract On loweriNg Blood Glucose in Pre-diabetics
Cinnamon Trial—Assessment of the effeCt of lIfestyle iNtervention Plus Water-soluble ciNnAMon Extract On loweriNg Blood Glucose in Pre-diabetics: A Randomized, Double-blind, Multicenter, Placebo Controlled TRIAL.
Status: Enrolling
Updated: 12/31/1969
Wilford Hall Ambulatory Surgical Center
mi
from
Lackland Air Force Base, TX
Click here to add this to my saved trials
FL3X Study: An Adaptive Intervention to Improve Outcomes for Youth With Type 1 Diabetes (FL3X)
FL3X: An Adaptive Intervention to Improve Outcomes for Youth With Type 1 Diabetes
Status: Enrolling
Updated:  12/31/1969
University of Colorado Barbara Davis Center for Childhood Diabetes
mi
from
Aurora, CO
FL3X Study: An Adaptive Intervention to Improve Outcomes for Youth With Type 1 Diabetes (FL3X)
FL3X: An Adaptive Intervention to Improve Outcomes for Youth With Type 1 Diabetes
Status: Enrolling
Updated: 12/31/1969
University of Colorado Barbara Davis Center for Childhood Diabetes
mi
from
Aurora, CO
Click here to add this to my saved trials
FL3X Study: An Adaptive Intervention to Improve Outcomes for Youth With Type 1 Diabetes (FL3X)
FL3X: An Adaptive Intervention to Improve Outcomes for Youth With Type 1 Diabetes
Status: Enrolling
Updated:  12/31/1969
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
FL3X Study: An Adaptive Intervention to Improve Outcomes for Youth With Type 1 Diabetes (FL3X)
FL3X: An Adaptive Intervention to Improve Outcomes for Youth With Type 1 Diabetes
Status: Enrolling
Updated: 12/31/1969
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Metformin Postpartum for GDM RCT for Reduced Weight Retention
The Effects of Metformin on Retained Postpartum Weight in Women With Gestational Diabetes: A Randomized, Placebo-Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Memorial Hermann Hospital, Texas Medical Center
mi
from
Houston, TX
Metformin Postpartum for GDM RCT for Reduced Weight Retention
The Effects of Metformin on Retained Postpartum Weight in Women With Gestational Diabetes: A Randomized, Placebo-Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Memorial Hermann Hospital, Texas Medical Center
mi
from
Houston, TX
Click here to add this to my saved trials
Metformin Postpartum for GDM RCT for Reduced Weight Retention
The Effects of Metformin on Retained Postpartum Weight in Women With Gestational Diabetes: A Randomized, Placebo-Controlled Trial
Status: Enrolling
Updated:  12/31/1969
University of Texas Health Science Center at Houston, Professional Building
mi
from
Houston, TX
Metformin Postpartum for GDM RCT for Reduced Weight Retention
The Effects of Metformin on Retained Postpartum Weight in Women With Gestational Diabetes: A Randomized, Placebo-Controlled Trial
Status: Enrolling
Updated: 12/31/1969
University of Texas Health Science Center at Houston, Professional Building
mi
from
Houston, TX
Click here to add this to my saved trials
Study of AC-201 in Patients With Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Phase II Study of AC-201 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  12/31/1969
National Research Institute
mi
from
Los Angeles, CA
Study of AC-201 in Patients With Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Phase II Study of AC-201 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
National Research Institute
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Study of AC-201 in Patients With Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Phase II Study of AC-201 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  12/31/1969
Catalina Research Institute
mi
from
Chino, CA
Study of AC-201 in Patients With Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Phase II Study of AC-201 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
Catalina Research Institute
mi
from
Chino, CA
Click here to add this to my saved trials
Study of AC-201 in Patients With Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Phase II Study of AC-201 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  12/31/1969
Clinical Research of South Florida
mi
from
Coral Gables, FL
Study of AC-201 in Patients With Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Phase II Study of AC-201 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
Clinical Research of South Florida
mi
from
Coral Gables, FL
Click here to add this to my saved trials
Study of AC-201 in Patients With Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Phase II Study of AC-201 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  12/31/1969
Jacksonville Impotence Treatment Center
mi
from
Jacksonville, FL
Study of AC-201 in Patients With Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Phase II Study of AC-201 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
Jacksonville Impotence Treatment Center
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Study of AC-201 in Patients With Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Phase II Study of AC-201 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  12/31/1969
Chicago Clinical Research Institute Inc.
mi
from
Chicago, IL
Study of AC-201 in Patients With Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Phase II Study of AC-201 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
Chicago Clinical Research Institute Inc.
mi
from
Chicago, IL
Click here to add this to my saved trials
Study of AC-201 in Patients With Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Phase II Study of AC-201 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  12/31/1969
Clinical Investigation Specialists, Inc.
mi
from
Gurnee, IL
Study of AC-201 in Patients With Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Phase II Study of AC-201 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
Clinical Investigation Specialists, Inc.
mi
from
Gurnee, IL
Click here to add this to my saved trials
Study of AC-201 in Patients With Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Phase II Study of AC-201 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  12/31/1969
Midwest Institute for Clinical Research
mi
from
Indianapolis, IN
Study of AC-201 in Patients With Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Phase II Study of AC-201 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
Midwest Institute for Clinical Research
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Study of AC-201 in Patients With Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Phase II Study of AC-201 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  12/31/1969
L-MARC Research Center
mi
from
Louisville, KY
Study of AC-201 in Patients With Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Phase II Study of AC-201 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
L-MARC Research Center
mi
from
Louisville, KY
Click here to add this to my saved trials
Study of AC-201 in Patients With Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Phase II Study of AC-201 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  12/31/1969
New Orleans Center for Clinical Research
mi
from
New Orleans, LA
Study of AC-201 in Patients With Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Phase II Study of AC-201 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
New Orleans Center for Clinical Research
mi
from
New Orleans, LA
Click here to add this to my saved trials
Study of AC-201 in Patients With Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Phase II Study of AC-201 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  12/31/1969
Sterling Research Group
mi
from
Cincinnati, OH
Study of AC-201 in Patients With Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Phase II Study of AC-201 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
Sterling Research Group
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Study of AC-201 in Patients With Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Phase II Study of AC-201 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  12/31/1969
PriMed Clinical Research
mi
from
Kettering, OH
Study of AC-201 in Patients With Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Phase II Study of AC-201 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
PriMed Clinical Research
mi
from
Kettering, OH
Click here to add this to my saved trials
Study of AC-201 in Patients With Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Phase II Study of AC-201 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  12/31/1969
National Clinical Research - Richmond, Inc.
mi
from
Richmond, VA
Study of AC-201 in Patients With Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Phase II Study of AC-201 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
National Clinical Research - Richmond, Inc.
mi
from
Richmond, VA
Click here to add this to my saved trials
Study of AC-201 in Patients With Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Phase II Study of AC-201 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  12/31/1969
Rainier Clinical Research Center Inc.
mi
from
Renton, WA
Study of AC-201 in Patients With Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Phase II Study of AC-201 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
Rainier Clinical Research Center Inc.
mi
from
Renton, WA
Click here to add this to my saved trials
Study of AC-201 in Patients With Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Phase II Study of AC-201 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  12/31/1969
Changhua Christian Hospital
mi
from
Changhua,
Study of AC-201 in Patients With Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Phase II Study of AC-201 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
Changhua Christian Hospital
mi
from
Changhua,
Click here to add this to my saved trials
Aggressive Versus Conservative Blood Glucose Control in Hospitalized Type 2 Diabetic Patients Using Detemir and Aspart Insulin
RAndomized SubCutaneous Insulin in INpatients (RASCIN) Trial: Aggressive Versus Conservative Blood Glucose Control in Hospitalized Type 2 Diabetic Patients Using Detemir and Aspart Insulin
Status: Enrolling
Updated:  12/31/1969
Parkland Memorial Hospital
mi
from
Dallas, TX
Aggressive Versus Conservative Blood Glucose Control in Hospitalized Type 2 Diabetic Patients Using Detemir and Aspart Insulin
RAndomized SubCutaneous Insulin in INpatients (RASCIN) Trial: Aggressive Versus Conservative Blood Glucose Control in Hospitalized Type 2 Diabetic Patients Using Detemir and Aspart Insulin
Status: Enrolling
Updated: 12/31/1969
Parkland Memorial Hospital
mi
from
Dallas, TX
Click here to add this to my saved trials
Healthy Volunteers Study of the Effects of Olanzapine and Ziprasidone
A Randomized Comparison of the Acute Effects of Olanzapine and Ziprasidone on Whole Body Insulin Sensitivity in Healthy Volunteers
Status: Enrolling
Updated:  12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
Healthy Volunteers Study of the Effects of Olanzapine and Ziprasidone
A Randomized Comparison of the Acute Effects of Olanzapine and Ziprasidone on Whole Body Insulin Sensitivity in Healthy Volunteers
Status: Enrolling
Updated: 12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Growth Hormone Feedback to Insulin-like Growth Factor-I (IGF-1) and Oral Glucose Tolerance Test (OGTT)
Growth Hormone Feedback In Patients With Acromegaly, Type 2 Diabetes Mellitus, And Healthy Adults
Status: Enrolling
Updated:  12/31/1969
Cedars-Sinai Medical Center, Pituitary Center
mi
from
Los Angeles, CA
Growth Hormone Feedback to Insulin-like Growth Factor-I (IGF-1) and Oral Glucose Tolerance Test (OGTT)
Growth Hormone Feedback In Patients With Acromegaly, Type 2 Diabetes Mellitus, And Healthy Adults
Status: Enrolling
Updated: 12/31/1969
Cedars-Sinai Medical Center, Pituitary Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Comprehensive Intervention for Diabetes and Comorbid Depression in Primary Care
A Comprehensive Intervention for Diabetes and Comorbid Depression in Primary Care
Status: Enrolling
Updated:  12/31/1969
Family and Community Medicine Clinic, University of Texas Southwestern Medical Center
mi
from
Dallas, TX
A Comprehensive Intervention for Diabetes and Comorbid Depression in Primary Care
A Comprehensive Intervention for Diabetes and Comorbid Depression in Primary Care
Status: Enrolling
Updated: 12/31/1969
Family and Community Medicine Clinic, University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Use of Continuous Glucose Sensors by Adolescents With Inadequate Diabetic Control
Use of Continuous Glucose Sensors by Adolescents With Inadequate Diabetic Control
Status: Enrolling
Updated:  12/31/1969
Nemours Children's Clinic
mi
from
Jacksonville, FL
Use of Continuous Glucose Sensors by Adolescents With Inadequate Diabetic Control
Use of Continuous Glucose Sensors by Adolescents With Inadequate Diabetic Control
Status: Enrolling
Updated: 12/31/1969
Nemours Children's Clinic
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Prevention of Cystic Fibrosis Diabetes
A Randomized, Double-blind, Placebo-controlled Study to Determine Whether Chronic Treatment of Cystic Fibrosis Subjects With Impaired Glucose Tolerance Using Sitagliptin (Januvia) Prevents the Development of Diabetes
Status: Enrolling
Updated:  12/31/1969
Emory University and Children's Healthcare of Atlanta at Egleston
mi
from
Atlanta, GA
Prevention of Cystic Fibrosis Diabetes
A Randomized, Double-blind, Placebo-controlled Study to Determine Whether Chronic Treatment of Cystic Fibrosis Subjects With Impaired Glucose Tolerance Using Sitagliptin (Januvia) Prevents the Development of Diabetes
Status: Enrolling
Updated: 12/31/1969
Emory University and Children's Healthcare of Atlanta at Egleston
mi
from
Atlanta, GA
Click here to add this to my saved trials
Prevention of Cystic Fibrosis Diabetes
A Randomized, Double-blind, Placebo-controlled Study to Determine Whether Chronic Treatment of Cystic Fibrosis Subjects With Impaired Glucose Tolerance Using Sitagliptin (Januvia) Prevents the Development of Diabetes
Status: Enrolling
Updated:  12/31/1969
Children's Healthcare of Atlanta @ Scottish Rite
mi
from
Atlanta, GA
Prevention of Cystic Fibrosis Diabetes
A Randomized, Double-blind, Placebo-controlled Study to Determine Whether Chronic Treatment of Cystic Fibrosis Subjects With Impaired Glucose Tolerance Using Sitagliptin (Januvia) Prevents the Development of Diabetes
Status: Enrolling
Updated: 12/31/1969
Children's Healthcare of Atlanta @ Scottish Rite
mi
from
Atlanta, GA
Click here to add this to my saved trials
Prevention of Cystic Fibrosis Diabetes
A Randomized, Double-blind, Placebo-controlled Study to Determine Whether Chronic Treatment of Cystic Fibrosis Subjects With Impaired Glucose Tolerance Using Sitagliptin (Januvia) Prevents the Development of Diabetes
Status: Enrolling
Updated:  12/31/1969
Nationwide Children's Hospital
mi
from
Columbus, OH
Prevention of Cystic Fibrosis Diabetes
A Randomized, Double-blind, Placebo-controlled Study to Determine Whether Chronic Treatment of Cystic Fibrosis Subjects With Impaired Glucose Tolerance Using Sitagliptin (Januvia) Prevents the Development of Diabetes
Status: Enrolling
Updated: 12/31/1969
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Safety Study of Recombinant Adeno-Associated Virus Acid Alpha-Glucosidase to Treat Pompe Disease
Phase I/II Trial of Diaphragm Delivery of Recombinant Adeno-Associated Virus Acid Alpha-Glucosidase (rAAV1-CMV-GAA) Gene Vector in Patients With Pompe Disease
Status: Enrolling
Updated:  12/31/1969
Shands at the University of Florida
mi
from
Gainesville, FL
Safety Study of Recombinant Adeno-Associated Virus Acid Alpha-Glucosidase to Treat Pompe Disease
Phase I/II Trial of Diaphragm Delivery of Recombinant Adeno-Associated Virus Acid Alpha-Glucosidase (rAAV1-CMV-GAA) Gene Vector in Patients With Pompe Disease
Status: Enrolling
Updated: 12/31/1969
Shands at the University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Basal Bolus Versus Basal Insulin in Type 2 Diabetes Mellitus (T2DM)
Basal Bolus Versus Basal Insulin Regimen for the Treatment of Hospitalized Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  12/31/1969
Grady Memorial Hospital
mi
from
Atlanta, GA
Basal Bolus Versus Basal Insulin in Type 2 Diabetes Mellitus (T2DM)
Basal Bolus Versus Basal Insulin Regimen for the Treatment of Hospitalized Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
Grady Memorial Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Basal Bolus Versus Basal Insulin in Type 2 Diabetes Mellitus (T2DM)
Basal Bolus Versus Basal Insulin Regimen for the Treatment of Hospitalized Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  12/31/1969
Emory University Hospital
mi
from
Atlanta, GA
Basal Bolus Versus Basal Insulin in Type 2 Diabetes Mellitus (T2DM)
Basal Bolus Versus Basal Insulin Regimen for the Treatment of Hospitalized Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
Emory University Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Basal Bolus Versus Basal Insulin in Type 2 Diabetes Mellitus (T2DM)
Basal Bolus Versus Basal Insulin Regimen for the Treatment of Hospitalized Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  12/31/1969
Atlanta VA Medical Center
mi
from
Decatur, GA
Basal Bolus Versus Basal Insulin in Type 2 Diabetes Mellitus (T2DM)
Basal Bolus Versus Basal Insulin Regimen for the Treatment of Hospitalized Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
Atlanta VA Medical Center
mi
from
Decatur, GA
Click here to add this to my saved trials
Basal Bolus Versus Basal Insulin in Type 2 Diabetes Mellitus (T2DM)
Basal Bolus Versus Basal Insulin Regimen for the Treatment of Hospitalized Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Basal Bolus Versus Basal Insulin in Type 2 Diabetes Mellitus (T2DM)
Basal Bolus Versus Basal Insulin Regimen for the Treatment of Hospitalized Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Basal Bolus Versus Basal Insulin in Type 2 Diabetes Mellitus (T2DM)
Basal Bolus Versus Basal Insulin Regimen for the Treatment of Hospitalized Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  12/31/1969
Scott and White Memorial Hospital & Clinic
mi
from
Temple, TX
Basal Bolus Versus Basal Insulin in Type 2 Diabetes Mellitus (T2DM)
Basal Bolus Versus Basal Insulin Regimen for the Treatment of Hospitalized Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
Scott and White Memorial Hospital & Clinic
mi
from
Temple, TX
Click here to add this to my saved trials
Cultivating Healthy Environments in Families With Type 1 Diabetes (CHEF)
Cultivating Healthy Environments in Families With Type 1 Diabetes (CHEF)
Status: Enrolling
Updated:  12/31/1969
Joslin Diabetes Center
mi
from
Boston, MA
Cultivating Healthy Environments in Families With Type 1 Diabetes (CHEF)
Cultivating Healthy Environments in Families With Type 1 Diabetes (CHEF)
Status: Enrolling
Updated: 12/31/1969
Joslin Diabetes Center
mi
from
Boston, MA
Click here to add this to my saved trials
Prevalence of Non-alcoholic Fatty Liver Disease (NAFLD) in Hispanics With Diabetes Mellitus Type 2 (T2DM) and Role of Treatment
NAFLD in T2DM: Prevalence in Hispanics and Role of Treatment
Status: Enrolling
Updated:  12/31/1969
North Florida/South Georgia Veterans Health System, Gainesville, FL
mi
from
Gainesville, FL
Prevalence of Non-alcoholic Fatty Liver Disease (NAFLD) in Hispanics With Diabetes Mellitus Type 2 (T2DM) and Role of Treatment
NAFLD in T2DM: Prevalence in Hispanics and Role of Treatment
Status: Enrolling
Updated: 12/31/1969
North Florida/South Georgia Veterans Health System, Gainesville, FL
mi
from
Gainesville, FL
Click here to add this to my saved trials
Prevalence of Non-alcoholic Fatty Liver Disease (NAFLD) in Hispanics With Diabetes Mellitus Type 2 (T2DM) and Role of Treatment
NAFLD in T2DM: Prevalence in Hispanics and Role of Treatment
Status: Enrolling
Updated:  12/31/1969
South Texas Health Care System, San Antonio, TX
mi
from
San Antonio, TX
Prevalence of Non-alcoholic Fatty Liver Disease (NAFLD) in Hispanics With Diabetes Mellitus Type 2 (T2DM) and Role of Treatment
NAFLD in T2DM: Prevalence in Hispanics and Role of Treatment
Status: Enrolling
Updated: 12/31/1969
South Texas Health Care System, San Antonio, TX
mi
from
San Antonio, TX
Click here to add this to my saved trials
Partners for Better Health in Adolescent Type 2 Diabetes: The Buddy Study
Partners for Better Health in Adolescent Type 2 Diabetes: The Buddy Study
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Partners for Better Health in Adolescent Type 2 Diabetes: The Buddy Study
Partners for Better Health in Adolescent Type 2 Diabetes: The Buddy Study
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Partners for Better Health in Adolescent Type 2 Diabetes: The Buddy Study
Partners for Better Health in Adolescent Type 2 Diabetes: The Buddy Study
Status: Enrolling
Updated:  12/31/1969
Childrens National Medical Center
mi
from
Washington,
Partners for Better Health in Adolescent Type 2 Diabetes: The Buddy Study
Partners for Better Health in Adolescent Type 2 Diabetes: The Buddy Study
Status: Enrolling
Updated: 12/31/1969
Childrens National Medical Center
mi
from
Washington,
Click here to add this to my saved trials
Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk"
AntiCD3 Mab (Teplizumab) For Prevention of Diabetes In Relatives At-Risk for Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk"
AntiCD3 Mab (Teplizumab) For Prevention of Diabetes In Relatives At-Risk for Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk"
AntiCD3 Mab (Teplizumab) For Prevention of Diabetes In Relatives At-Risk for Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk"
AntiCD3 Mab (Teplizumab) For Prevention of Diabetes In Relatives At-Risk for Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk"
AntiCD3 Mab (Teplizumab) For Prevention of Diabetes In Relatives At-Risk for Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  12/31/1969
Stanford University
mi
from
Stanford, CA
Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk"
AntiCD3 Mab (Teplizumab) For Prevention of Diabetes In Relatives At-Risk for Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
Stanford University
mi
from
Stanford, CA
Click here to add this to my saved trials
Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk"
AntiCD3 Mab (Teplizumab) For Prevention of Diabetes In Relatives At-Risk for Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  12/31/1969
Barbara Davis Center for Childhood Diabetes/ University of Colorado
mi
from
Denver, CO
Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk"
AntiCD3 Mab (Teplizumab) For Prevention of Diabetes In Relatives At-Risk for Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
Barbara Davis Center for Childhood Diabetes/ University of Colorado
mi
from
Denver, CO
Click here to add this to my saved trials
Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk"
AntiCD3 Mab (Teplizumab) For Prevention of Diabetes In Relatives At-Risk for Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  12/31/1969
Yale University School of Medicine
mi
from
New Haven, CT
Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk"
AntiCD3 Mab (Teplizumab) For Prevention of Diabetes In Relatives At-Risk for Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
Yale University School of Medicine
mi
from
New Haven, CT
Click here to add this to my saved trials
Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk"
AntiCD3 Mab (Teplizumab) For Prevention of Diabetes In Relatives At-Risk for Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  12/31/1969
University of Miami
mi
from
Miami, FL
Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk"
AntiCD3 Mab (Teplizumab) For Prevention of Diabetes In Relatives At-Risk for Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk"
AntiCD3 Mab (Teplizumab) For Prevention of Diabetes In Relatives At-Risk for Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  12/31/1969
Indiana University
mi
from
Indianapolis, IN
Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk"
AntiCD3 Mab (Teplizumab) For Prevention of Diabetes In Relatives At-Risk for Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
Indiana University
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk"
AntiCD3 Mab (Teplizumab) For Prevention of Diabetes In Relatives At-Risk for Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  12/31/1969
Univ of Minnesota
mi
from
Minneapolis, MN
Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk"
AntiCD3 Mab (Teplizumab) For Prevention of Diabetes In Relatives At-Risk for Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk"
AntiCD3 Mab (Teplizumab) For Prevention of Diabetes In Relatives At-Risk for Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  12/31/1969
Columbia University
mi
from
New York, NY
Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk"
AntiCD3 Mab (Teplizumab) For Prevention of Diabetes In Relatives At-Risk for Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
Columbia University
mi
from
New York, NY
Click here to add this to my saved trials